First Vaccine Data Against Indian Variant

Both the Pfizer and AstraZeneca COVID-19 vaccines showed effectiveness against symptomatic disease from B.1.617.2, the so-called Indian variant, British researchers found. Two doses of Pfizer’s vaccine showed 87.9% efficacy (95% CI 78.2%-93.2%) …

Read more at www.medpagetoday.com